← Back to guidelines
Emergency Medicine68 papers

Acute paralytic poliomyelitis

Last edited: 4/14/2026

Overview

Acute paralytic poliomyelitis is a highly infectious viral disease caused by poliovirus, leading to paralysis, primarily affecting children but capable of causing severe neurological complications in any age group 1. Historically significant, current cases are rare due to widespread vaccination efforts 1.

Diagnosis

  • Clinical presentation includes acute onset of flaccid paralysis, often asymmetric, with muscle weakness and atrophy 1.
  • Laboratory confirmation involves detecting poliovirus in stool samples or throat swabs, typically within the first three weeks of symptom onset 1.
  • Electromyography (EMG) and nerve conduction studies may show characteristic changes indicative of lower motor neuron lesions 1.
  • Management

  • Supportive care: Focus on respiratory support, physical therapy, and pain management for affected individuals 1.
  • No specific antiviral treatment: Currently, there are no antiviral drugs approved for the treatment of acute paralytic poliomyelitis 1.
  • Immunoglobulin therapy: Some studies suggest potential benefits, though evidence is limited and not universally recommended 1.
  • Special Populations

  • Pregnancy: Limited data; management focuses on supportive care with close monitoring of maternal and fetal status 1.
  • Pediatrics: Primary affected group; vaccination remains the cornerstone of prevention 1.
  • Elderly: Less common but can occur; management mirrors that of other age groups with emphasis on supportive care 1.
  • Comorbidities: Presence complicates management; tailored supportive care addressing specific comorbidities is essential 1.
  • Key Recommendations

  • Vaccination: Implement and maintain high vaccination coverage to prevent outbreaks (Evidence: Expert opinion 1).
  • Early diagnosis and supportive care: Prompt identification and comprehensive supportive care including respiratory support and physical therapy are crucial (Evidence: Expert opinion 1).
  • Monitoring in special populations: Tailor monitoring and management strategies for pregnant women, children, and elderly patients due to varying clinical presentations and needs (Evidence: Expert opinion 1).
  • References

    1 Healey J. "A Vile Custom": The Strange Career of William Osler's "Professional Notes". Journal of the history of medicine and allied sciences 2025. link 2 Hugelius K, Nandain C, Semrau M, Holmefur M. The Reliability and Feasibility of the HESPER Web to Assess Perceived Needs in a Population Affected by a Humanitarian Emergency. International journal of environmental research and public health 2021. link 3 Hugelius K, Semrau M, Holmefur M. HESPER web - development and reliability evaluation of a web-based version of the humanitarian emergency settings perceived needs scale. BMC public health 2020. link 4 Jumah NA, Wilson D, Shah R. A Canadian survey of postgraduate education in Aboriginal women's health in obstetrics and gynaecology. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2013. link30891-4)

    Original source

    1. [1]
      "A Vile Custom": The Strange Career of William Osler's "Professional Notes".Healey J Journal of the history of medicine and allied sciences (2025)
    2. [2]
      The Reliability and Feasibility of the HESPER Web to Assess Perceived Needs in a Population Affected by a Humanitarian Emergency.Hugelius K, Nandain C, Semrau M, Holmefur M International journal of environmental research and public health (2021)
    3. [3]
    4. [4]
      A Canadian survey of postgraduate education in Aboriginal women's health in obstetrics and gynaecology.Jumah NA, Wilson D, Shah R Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC (2013)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG